KN
Karaikal Narayanaswamy Murali Krishnan
About Karaikal Narayanaswamy Murali Krishnan
Data last updated:
Karaikal Narayanaswamy Murali Krishnan is a Director at Biocon Pharma Limited (since 2022) and Director at Biocon Biosphere Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹996 Cr; the largest is Biocon Pharma Limited at ₹982 Cr (FY 2025). Earlier, Karaikal Narayanaswamy Murali Krishnan was a Director at Biofusion Therapeutics Limited (from 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biocon Pharma Limited U24232KA2014PLC077036 | Director | 13 May 2022 | 2014 | ₹982 Cr (FY 2025) | Active |
| Biocon Biosphere Limited U24304KA2019PLC130965 | Director | 13 May 2022 | 2019 | ₹13.00 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biofusion Therapeutics Limited U73100KA2021PLC145487 | Director | 27 Jul 2022 | 2021 | ₹56.53 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Karaikal Narayanaswamy Murali Krishnan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kiran Mazumdar Shaw | 00347229 | Biocon Pharma Limited , Biocon Biosphere Limited | Director |
| Mayank Verma | Biocon Pharma Limited | Company Secretary | |
| Siddharth Mittal | 03230757 | Biocon Pharma Limited , Biocon Biosphere Limited | Whole-Time Director |
| Soudabi Neduvanchery | 07508179 | Biocon Pharma Limited | Cfo |
| Soudabi Neduvanchery | Biocon Pharma Limited | Cfo | |
| Ekta Agarwal | 07158376 | Biocon Biosphere Limited | Company Secretary |
| Ms. Ekta Agarwal | Biocon Biosphere Limited | Company Secretary | |
| Mukesh Kamath | Biocon Biosphere Limited | Cfo | |
| Peter Bains | Biocon Biosphere Limited | Ceo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karaikal Narayanaswamy Murali Krishnan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karaikal Narayanaswamy Murali Krishnan
Karaikal Narayanaswamy Murali Krishnan currently holds 2 directorships: Biocon Pharma Limited (Director, since 13 May 2022, revenue ₹982 Cr (FY 2025)); Biocon Biosphere Limited (Director, since 13 May 2022, revenue ₹13.00 Cr (FY 2025)).
Karaikal Narayanaswamy Murali Krishnan was first appointed on 13 May 2022 as Director at Biocon Pharma Limited.
The 2 current companies of Karaikal Narayanaswamy Murali Krishnan that report revenue have a combined latest revenue of ₹996 Cr: Biocon Pharma Limited ₹982 Cr (FY 2025); Biocon Biosphere Limited ₹13.00 Cr (FY 2025).
Karaikal Narayanaswamy Murali Krishnan held 1 earlier board appointment: Biofusion Therapeutics Limited (Director, from 27 Jul 2022).
The current boards of Karaikal Narayanaswamy Murali Krishnan's companies include Kiran Mazumdar Shaw (Biocon Pharma Limited), Mayank Verma (Biocon Pharma Limited), Siddharth Mittal (Biocon Pharma Limited), Soudabi Neduvanchery (Biocon Pharma Limited), Soudabi Neduvanchery (Biocon Pharma Limited), Ekta Agarwal (Biocon Biosphere Limited), among others.